The 1.85 A structure of vaccinia protein VP39: a bifunctional enzyme that participates in the modification of both mRNA ends

Cell. 1996 Apr 19;85(2):247-56. doi: 10.1016/s0092-8674(00)81101-0.

Abstract

VP39 is a bifunctional vaccinia virus protein that acts as both an mRNA cap-specific RNA 2'-O-methyltransferase and a poly(A) polymerase processivity factor. Here, we report the 1.85 A crystal structure of a VP39 variant complexed with its AdoMet cofactor. VP39 comprises a single core domain with structural similarity to the catalytic domains of other methyltransferases. Surface features and mutagenesis data suggest two possible RNA-binding sites with novel underlying architecture, one of which forms a cleft spanning the region adjacent to the methyltransferase active site. This report provides a prototypic structure for an RNA methyltransferase, a protein that interacts with the mRNA 5' cap, and an intact poxvirus protein.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Binding Sites / physiology
  • Biological Evolution
  • Crystallography, X-Ray
  • Image Processing, Computer-Assisted
  • Methyltransferases / chemistry
  • Protein Conformation
  • Protein Structure, Secondary
  • Protein Structure, Tertiary
  • RNA Caps / chemistry
  • RNA, Messenger / metabolism*
  • S-Adenosylmethionine / metabolism
  • Vaccinia virus / chemistry
  • Vaccinia virus / enzymology*
  • Viral Proteins / chemistry*
  • Viral Proteins / metabolism

Substances

  • RNA Caps
  • RNA, Messenger
  • VP39 protein, Vaccinia virus
  • Viral Proteins
  • S-Adenosylmethionine
  • Methyltransferases